|
Volumn 22, Issue 4, 2002, Pages 261-262
|
Disclosing the "inclusion benefit"
a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOTROPIN;
PENICILLIN G;
STREPTOMYCIN;
CLINICAL TRIAL;
CONGENITAL SYPHILIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EDITORIAL;
GROWTH DISORDER;
HUMAN;
INFORMED CONSENT;
LUNG TUBERCULOSIS;
MEDICAL DECISION MAKING;
NEWBORN;
RANDOMIZED CONTROLLED TRIAL;
RESPONSIBILITY;
RETROLENTAL FIBROPLASIA;
SPIROCHETE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
CLINICAL TRIALS;
HUMANS;
INFORMED CONSENT;
PHYSICIAN-PATIENT RELATIONS;
|
EID: 0036269560
PISSN: 07438346
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jp.7210700 Document Type: Editorial |
Times cited : (4)
|
References (12)
|